(AXON) Axon Enterprise - Ratings and Ratios
Taser, Body Cameras, Evidence Software, Cloud Platform
AXON EPS (Earnings per Share)
AXON Revenue
Description: AXON Axon Enterprise September 26, 2025
Axon Enterprise, Inc. (NASDAQ: AXON) designs, manufactures, and sells conducted-energy devices (CEDs) under the TASER brand, alongside a suite of hardware and cloud-based software solutions that enable law-enforcement agencies to capture, store, manage, share, and analyze digital evidence.
The business is organized into two primary segments: (1) TASER, which generates revenue from the sale of CEDs and related accessories (e.g., cartridges, batteries, and extended warranties); and (2) Software & Sensors, which includes body-worn cameras, in-car video systems, and a portfolio of subscription-based evidence-management platforms such as Axon Records, Evidence, and Command.
Axon reaches customers through a mixed-channel model that combines direct sales teams, a network of distribution partners, an online storefront, and third-party resellers; a strategic partnership with Fusus, Inc. expands its capability to aggregate live video, data, and sensor feeds across multiple devices.
The company serves a broad public-safety ecosystem that includes municipal police, federal agencies, corrections, fire and EMS, campus security, private-security firms, and individual consumers seeking personal-safety products.
According to Axon’s FY 2023 earnings release, total revenue reached approximately $1.44 billion, with software-as-a-service (SaaS) subscriptions accounting for roughly 70 % of recurring revenue and growing at a compound annual rate of ~30 % over the prior three years. Gross margins improved to ~71 % driven by the higher-margin SaaS mix, while operating cash flow turned positive in Q4 2023.
Key macro drivers for Axon include municipal budget cycles (which can constrain capital-expenditure on new equipment), the ongoing shift toward digital evidence workflows in law-enforcement agencies, and broader public-policy debates around the use of conducted-energy weapons that can affect adoption rates.
For a deeper, data-driven assessment of Axon’s valuation assumptions and scenario analysis, you may find the research tools on ValueRay worth exploring.
AXON Stock Overview
| Market Cap in USD | 55,320m |
| Sub-Industry | Aerospace & Defense |
| IPO / Inception | 2001-06-07 |
AXON Stock Ratings
| Growth Rating | 88.1% |
| Fundamental | 58.0% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | 40.2% |
| Analyst Rating | 4.24 of 5 |
AXON Dividends
Currently no dividends paidAXON Growth Ratios
| Growth Correlation 3m | -71.3% |
| Growth Correlation 12m | 68.4% |
| Growth Correlation 5y | 88.6% |
| CAGR 5y | 73.92% |
| CAGR/Max DD 3y (Calmar Ratio) | 2.46 |
| CAGR/Mean DD 3y (Pain Ratio) | 9.56 |
| Sharpe Ratio 12m | 1.41 |
| Alpha | 40.64 |
| Beta | 1.415 |
| Volatility | 44.38% |
| Current Volume | 383.8k |
| Average Volume 20d | 456.2k |
| Stop Loss | 704 (-4.3%) |
| Signal | 0.35 |
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income (326.3m TTM) > 0 and > 6% of Revenue (6% = 143.5m TTM) |
| FCFTA 0.03 (>2.0%) and ΔFCFTA -2.61pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 105.8% (prev 79.68%; Δ 26.16pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.04 (>3.0%) and CFO 275.6m <= Net Income 326.3m (YES >=105%, WARN >=100%) |
| Net Debt (1.44b) to EBITDA (334.1m) ratio: 4.30 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.95 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (82.1m) change vs 12m ago 5.82% (target <= -2.0% for YES) |
| Gross Margin 60.47% (prev 60.08%; Δ 0.39pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 48.04% (prev 48.28%; Δ -0.24pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 6.84 (EBITDA TTM 334.1m / Interest Expense TTM 40.0m) >= 6 (WARN >= 3) |
Altman Z'' 3.81
| (A) 0.41 = (Total Current Assets 3.83b - Total Current Liabilities 1.30b) / Total Assets 6.22b |
| (B) 0.15 = Retained Earnings (Balance) 936.1m / Total Assets 6.22b |
| (C) 0.05 = EBIT TTM 273.6m / Avg Total Assets 4.98b |
| (D) 0.27 = Book Value of Equity 923.4m / Total Liabilities 3.48b |
| Total Rating: 3.81 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 58.02
| 1. Piotroski 3.50pt = -1.50 |
| 2. FCF Yield 0.32% = 0.16 |
| 3. FCF Margin 7.38% = 1.84 |
| 4. Debt/Equity 0.75 = 2.23 |
| 5. Debt/Ebitda 4.30 = -2.50 |
| 6. ROIC - WACC (= -1.16)% = -1.46 |
| 7. RoE 13.43% = 1.12 |
| 8. Rev. Trend 99.78% = 7.48 |
| 9. EPS Trend 12.90% = 0.65 |
What is the price of AXON shares?
Over the past week, the price has changed by +7.73%, over one month by +3.82%, over three months by -0.05% and over the past year by +65.47%.
Is Axon Enterprise a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of AXON is around 1042.11 USD . This means that AXON is currently undervalued and has a potential upside of +41.6% (Margin of Safety).
Is AXON a buy, sell or hold?
- Strong Buy: 7
- Buy: 7
- Hold: 3
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the AXON price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 888.9 | 20.8% |
| Analysts Target Price | 888.9 | 20.8% |
| ValueRay Target Price | 1186.2 | 61.2% |
AXON Fundamental Data Overview October 16, 2025
P/E Trailing = 172.2909
P/E Forward = 84.7458
P/S = 23.1309
P/B = 20.7015
P/EG = 2.86
Beta = 1.415
Revenue TTM = 2.39b USD
EBIT TTM = 273.6m USD
EBITDA TTM = 334.1m USD
Long Term Debt = 1.73b USD (from longTermDebt, last quarter)
Short Term Debt = 279.2m USD (from shortTermDebt, last quarter)
Debt = 2.05b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.44b USD (from netDebt column, last quarter)
Enterprise Value = 55.28b USD (55.32b + Debt 2.05b - CCE 2.09b)
Interest Coverage Ratio = 6.84 (Ebit TTM 273.6m / Interest Expense TTM 40.0m)
FCF Yield = 0.32% (FCF TTM 176.5m / Enterprise Value 55.28b)
FCF Margin = 7.38% (FCF TTM 176.5m / Revenue TTM 2.39b)
Net Margin = 13.64% (Net Income TTM 326.3m / Revenue TTM 2.39b)
Gross Margin = 60.47% ((Revenue TTM 2.39b - Cost of Revenue TTM 945.5m) / Revenue TTM)
Gross Margin QoQ = 60.39% (prev 60.59%)
Tobins Q-Ratio = 8.89 (Enterprise Value 55.28b / Total Assets 6.22b)
Interest Expense / Debt = 1.40% (Interest Expense 28.7m / Debt 2.05b)
Taxrate = 192.9% (out of range, set to none) (-75.0m / -38.9m)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 2.95 (Total Current Assets 3.83b / Total Current Liabilities 1.30b)
Debt / Equity = 0.75 (Debt 2.05b / totalStockholderEquity, last quarter 2.73b)
Debt / EBITDA = 4.30 (Net Debt 1.44b / EBITDA 334.1m)
Debt / FCF = 8.14 (Net Debt 1.44b / FCF TTM 176.5m)
Total Stockholder Equity = 2.43b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.25% (Net Income 326.3m / Total Assets 6.22b)
RoE = 13.43% (Net Income TTM 326.3m / Total Stockholder Equity 2.43b)
RoCE = 6.58% (EBIT 273.6m / Capital Employed (Equity 2.43b + L.T.Debt 1.73b))
RoIC = 9.66% (EBIT 273.6m / (Assets 6.22b - Curr.Liab 1.30b - Cash 2.09b))
WACC = 10.83% (E(55.32b)/V(57.37b) * Re(11.23%) + (debt cost/tax rate unavailable))
Discount Rate = 11.23% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 3.79%
[DCF Debug] Terminal Value 71.79% ; FCFE base≈187.4m ; Y1≈231.2m ; Y5≈394.5m
Fair Price DCF = 51.45 (DCF Value 4.04b / Shares Outstanding 78.5m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 12.90 | EPS CAGR: -51.14% | SUE: -4.0 | # QB: 0
Revenue Correlation: 99.78 | Revenue CAGR: 31.97% | SUE: 4.0 | # QB: 13
Additional Sources for AXON Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle